1.Clauss, RP, van der Merwe, CE, and Nel, HW. Arousal from a semi-comatose state on zolpidem. S Afr Med J. 2001; 91:788-789. 2.Clauss, RP, Guldenpfennig, WM, Nel, HW, et al. Extraordinary arousal from semi-comatose state on zolpidem. A case report. S Afr Med J. 2000; 90:68-72. 3.Cohen, SI and Duong, TT. Increased arousal in a patient with anoxic brain injury after administration of zolpidem. Am J Phys Med Rehabil. 2008; 87:229-231. 4.Singh, R, McDonald, C, Dawson, K, et al. Zolpidem in a minimally conscious state. Brain Inj. 2008; 22:103-106. 5.Whyte, J and Myers, R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Am J Phys Med Rehabil. 2009; 88:410-418. 6.Dang, A, Garg, A, and Rataboli, PV. Role of Zolpidem in the Management of Insomnia. CNS Neurosci Ther. 2010. 7.Shames, JL and Ring, H. Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: a case report. Arch Phys Med Rehabil. 2008; 89:386-388. 8.Clauss, RP and Nel, WH. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans. Arzneimittelforschung. 2004; 54:641-646. 9.Snyman, N, Egan, JR, London, K, et al. Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics. Neuropediatrics. 2010; 41:223-227. 10.Yang, W, Dollear, M, and Muthukrishnan, SR. One rare side effect of zolpidem--sleepwalking: a case report. Arch Phys Med Rehabil. 2005; 86:1265-1266. 11.Clauss, RP and Nel, WH. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans. Arzneimittelforschung. 2004; 54:641-646. 12.Cohen, SI and Duong, TT. Increased arousal in a patient with anoxic brain injury after administration of zolpidem. Am J Phys Med Rehabil. 2008; 87:229-231. 13.19. Giacino, JT and Malone, R. The vegetative and minimally conscious States. Handb Clin Neurol. 2008; 90:99-111. 14.20. Medical aspects of the persistent vegetative state (2). The Multi-Society Task Force on PVS. N Engl J Med. 1994; 330:1572-1579. 15.21. Medical aspects of the persistent vegetative state (1). The Multi-Society Task Force on PVS. N Engl J Med. 1994; 330:1499-1508. 16.Giacino, JT. The vegetative and minimally conscious states: consensus-based criteria for establishing diagnosis and prognosis. NeuroRehabilitation. 2004; 19:293-298. 17.Giacino, JT, Kalmar, K, and Whyte, J. The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil. 2004; 85:2020-2029. 18.Giacino, JT and Trott, CT. Rehabilitative management of patients with disorders of consciousness: grand rounds. J Head Trauma Rehabil. 2004; 19:254-265. 19.Kalmar, K and Giacino, JT. The JFK Coma Recovery Scale--Revised. Neuropsychol Rehabil. 2005; 15:454-460. 20.Montes-Brown, J, Machado, A, Estevez, M, et al. Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2. Acta Neurol Scand. 2012; 125:24-29. 21.Montes-Brown, J, Sanchez-Cruz, G, Garcia, AM, et al. Heart rate variability in type 2 spinocerebellar ataxia. Acta Neurol Scand. 2010; 122:329-335. 22.Elsenbruch, S, Wang, Z, Orr, WC, et al. Time-frequency analysis of heart rate variability using short-time fourier analysis. Physiol Meas. 2000; 21:229-240. 23.Seely, AJ and Macklem, PT. Complex systems and the technology of variability analysis. Crit Care. 2004; 8:R367-R384. 24.Martinmaki, K and Rusko, H. Time-frequency analysis of heart rate variability during immediate recovery from low and high intensity exercise. Eur J Appl Physiol. 2008; 102:353-360. 25.Martinmaki, K, Rusko, H, Saalasti, S, et al. Ability of short-time Fourier transform method to detect transient changes in vagal effects on hearts: a pharmacological blocking study. Am J Physiol Heart Circ Physiol. 2006; 290:H2582-H2589. 26.de Souza Neto, EP, Abry, P, Loiseau, P, et al. Empirical mode decomposition to assess cardiovascular autonomic control in rats. Fundam Clin Pharmacol. 2007; 21:481-496. 27.Oppenheim AV and Shafer RW. Discrete-Time Signal Processing.: Prentice Hall Enhelwood Ciffs NJ, 1989. 28.Schiff, ND, Ribary, U, Moreno, DR, et al. Residual cerebral activity and behavioural fragments can remain in the persistently vegetative brain. Brain. 2002; 125:1210-1234. 29.Shah, SA and Schiff, ND. Central thalamic deep brain stimulation for cognitive neuromodulation - a review of proposed mechanisms and investigational studies. Eur J Neurosci. 2010; 32:1135-1144. 30.Lloyd, GK, Lowenthal, A, Javoy-Agid, F, et al. GABAA receptor complex function in frontal cortex membranes from control and neurological patients. Eur J Pharmacol. 1991; 197:33-39. 31.Maric, D, Maric, I, Wen, X, et al. GABAA receptor subunit composition and functional properties of Cl- channels with differential sensitivity to zolpidem in embryonic rat hippocampal cells. J Neurosci. 1999; 19:4921-4937. 32.Maeda, J, Suhara, T, Kawabe, K, et al. Visualization of alpha5 subunit of GABAA/benzodiazepine receptor by 11C Ro15-4513 using positron emission tomography. Synapse. 2003; 47:200-208. 33.Hall, SD, Yamawaki, N, Fisher, AE, et al. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report. Clin Neurophysiol. 2010; 121:549-555. 34.Whyte, J and Myers, R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Am J Phys Med Rehabil. 2009; 88:410-418. 35.Hernández LP, García-Roca M de la C, Machado C. Predicting clinical course in comatose patients by evoked potentials. Clinical Neurophysiology 2003;114:165. 36.Machado C. Resolución para la determinación y certificación de la muerte en Cuba. Rev Neurol 2003; 36(8):763-770. 37.Machado C. A definition of human death should not be related to organ transplants. J Med Ethics 2003; 29(3):201-202 38.Machado C and Shewmon DA, eds. Brain Death and Consciousness Disorders. Advances in Experimental Medicine and Biology, Vol. 550. New York: Kluwer Academic/Plenum Publishers 2004:1-283. 39.Facco E, Machado C. Evoked potentials in the diagnosis of brain death. Adv Exp Med Biol. 2004;550:175-87. 40.Machado C. Can vegetative patients retain cortical processing? Clinical Neurophysiology 2005;116 2253–2254. 41.Machado C. Cerebral processing in the minimally conscious state. Neurology 2005; 65(6):973-4; author reply 973-4. 42.Machado C, García OD, Gutiérrez J, Portela L, García MC. Heart rate variability in comatose and brain-dead patients Clin Neurophysiol. 2005;116(12):2859-60. 43.Machado C. Terminating artificial nutrition and hydration in persistent vegetative state patients: current and proposed state laws. Neurology. 2007 Jan 23;68(4):312; author reply 312-313. 44.Machado C, Korein J, Ferrer Y, Portela L, García M de la C, Manero JM. The concept of brain death did not evolve to benefit organ transplants. Journal of Medical Ethics J. Med. Ethics, Apr 2007; 33: 197 - 200. 45.Machado C, Korein J, Aubert E, Bosch J, Álvarez MA, Rodríguez R, Valdés P, Portela L, García M, Pérez N, Chinchilla M, Machado Y, Machado Y. Recognizing a mother’s voice in the persistent vegetative state. Clinical EEG and Neuroscience 2007; 38(3):124-126. 46.Cuspineda E, Machado C, Galán L, Aubert E, Alvarez MA, Llopis F, Portela L, García M, Manero JM and Ávila Y. QEEG Prognostic Value in Acute Stroke. Clinical EEG and Neuroscience 2007; 38(3):155-160 47.Machado C. Cerebral response to patient's own name in the vegetative and minimally conscious states. Neurology 2007 Aug 14;69(7):708; author reply 708-9. 48.Machado C. Brain Death: A reappraisal. New York: Springer 2007:1-126.